Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a multi-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and PK parameter of HL-1186 tablet for diabetic peripheral neuropathic pain.
Epistemonikos ID: b98ceac8ce7366a5978a1dbaa43ef682a1c03ee1
First added on: Sep 09, 2025